NCT00782613 Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis Status TERMINATED Phase PHASE2
NCT00778700 A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00773734 Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) Status COMPLETED Phase PHASE2
NCT00769184 Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis Status COMPLETED Phase NA
NCT00763555 Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT00763204 A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test Status COMPLETED Phase PHASE1
NCT00762658 A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test Status COMPLETED Phase PHASE1
NCT00760669 An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants Status COMPLETED Phase N/A
NCT00759161 Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT00755196 Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT00749398 Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) Status COMPLETED Phase N/A
NCT00747344 A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet Status COMPLETED Phase PHASE4
NCT00727298 Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) Status COMPLETED Phase N/A
NCT00725452 Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900) Status COMPLETED Phase N/A
NCT00725348 An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT00723528 An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis Status COMPLETED Phase PHASE3